related documents
- 1854 Magnitude of, and risk factors for, stroke in patients with acute coronary syndromes. The global registry of acute coronary events Conferences
- 2047 Consistent benefit of clopidogrel in patients with non-ST-elevation acute coronary syndromes undergoing very early, early or later percutaneous coronary intervention in the CURE study Conferences
- 2055 Which factors determine the application of reperfusion therapy in ST-elevation acute coronary syndromes? Lessons from the Euro-Heart acute coronary syndromes survey Conferences
- Aspirin dose and bleeding events in the CURE study Conferences
- Mortality in left ventricular dysfunction treated with angiotensin-converting enzyme inhibitors. Ten-years follow-up post SOLVD close out Conferences
- P1572 In the fibrillating atria the mitochondrial sublimons are significantly correlated with both left atrial diameter and atrial fibrillation duration Conferences
- P2865 Treating patients with acute coronary syndromes with aggressive anti-platelet agents in the grace registry: no observed decrease in in-hospital mortality but increased bleeding complications Conferences
- The risks versus benefits of clopidogrel treatment in acute coronary syndrome patients overall, and those undergoing CABG: the CURE trial Conferences